112 related articles for article (PubMed ID: 11086167)
21. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.
Riese RJ; Wolf PR; Brömme D; Natkin LR; Villadangos JA; Ploegh HL; Chapman HA
Immunity; 1996 Apr; 4(4):357-66. PubMed ID: 8612130
[TBL] [Abstract][Full Text] [Related]
22. Invariant chain controls the activity of extracellular cathepsin L.
Fiebiger E; Maehr R; Villadangos J; Weber E; Erickson A; Bikoff E; Ploegh HL; Lennon-Duménil AM
J Exp Med; 2002 Nov; 196(9):1263-9. PubMed ID: 12417635
[TBL] [Abstract][Full Text] [Related]
23. Expression of invariant chain and pro-cathepsin L in Alzheimer's brain.
Yoshiyama Y; Arai K; Oki T; Hattori T
Neurosci Lett; 2000 Aug; 290(2):125-8. PubMed ID: 10936693
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.
Nakagawa T; Roth W; Wong P; Nelson A; Farr A; Deussing J; Villadangos JA; Ploegh H; Peters C; Rudensky AY
Science; 1998 Apr; 280(5362):450-3. PubMed ID: 9545226
[TBL] [Abstract][Full Text] [Related]
25. Thyroid functions of mouse cathepsins B, K, and L.
Friedrichs B; Tepel C; Reinheckel T; Deussing J; von Figura K; Herzog V; Peters C; Saftig P; Brix K
J Clin Invest; 2003 Jun; 111(11):1733-45. PubMed ID: 12782676
[TBL] [Abstract][Full Text] [Related]
26. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S.
Riese RJ; Shi GP; Villadangos J; Stetson D; Driessen C; Lennon-Dumenil AM; Chu CL; Naumov Y; Behar SM; Ploegh H; Locksley R; Chapman HA
Immunity; 2001 Dec; 15(6):909-19. PubMed ID: 11754813
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families.
Molina F; Bouanani M; Pau B; Granier C
Eur J Biochem; 1996 Aug; 240(1):125-33. PubMed ID: 8797845
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.
Zavasnik-Bergant V; Schweiger A; Bevec T; Golouh R; Turk V; Kos J
Immunology; 2004 Jul; 112(3):378-85. PubMed ID: 15196205
[TBL] [Abstract][Full Text] [Related]
29. Individual recombinant thyroglobulin type-1 domains are substrates for lysosomal cysteine proteinases.
Pungercic G; Dolenc I; Dolinar M; Bevec T; Jenko S; Kolaric S; Turk V
Biol Chem; 2002 Nov; 383(11):1809-12. PubMed ID: 12530546
[TBL] [Abstract][Full Text] [Related]
30. Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.
Reich M; Zou F; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
Cell Immunol; 2011; 269(2):96-103. PubMed ID: 21543057
[TBL] [Abstract][Full Text] [Related]
31. Sea bass (Dicentrarchus labrax) invariant chain and class II major histocompatibility complex: sequencing and structural analysis using 3D homology modelling.
Silva DS; Reis MI; Nascimento DS; do Vale A; Pereira PJ; dos Santos NM
Mol Immunol; 2007 Jul; 44(15):3758-76. PubMed ID: 17512596
[TBL] [Abstract][Full Text] [Related]
32. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment.
Maubach G; Lim MC; Kumar S; Zhuo L
Biochim Biophys Acta; 2007 Feb; 1773(2):219-31. PubMed ID: 17178165
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.
Beers C; Honey K; Fink S; Forbush K; Rudensky A
J Exp Med; 2003 Jan; 197(2):169-79. PubMed ID: 12538657
[TBL] [Abstract][Full Text] [Related]
34. Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family.
Katunuma N; Kakegawa H; Matsunaga Y; Saibara T
FEBS Lett; 1994 Aug; 349(2):265-9. PubMed ID: 8050579
[TBL] [Abstract][Full Text] [Related]
35. Shark class II invariant chain reveals ancient conserved relationships with cathepsins and MHC class II.
Criscitiello MF; Ohta Y; Graham MD; Eubanks JO; Chen PL; Flajnik MF
Dev Comp Immunol; 2012 Mar; 36(3):521-33. PubMed ID: 21996610
[TBL] [Abstract][Full Text] [Related]
36. Dual concentration-dependent activity of thyroglobulin type-1 domain of testican: specific inhibitor and substrate of cathepsin L.
Meh P; Pavsic M; Turk V; Baici A; Lenarcic B
Biol Chem; 2005 Jan; 386(1):75-83. PubMed ID: 15843150
[TBL] [Abstract][Full Text] [Related]
37. Molecular cloning and site-directed mutagenesis of leucine-based sorting motifs of the porcine invariant chain.
Xu FZ; Dai Y; Li LM; Ding XL; Yu WY
Genet Mol Res; 2013 Jan; 12(4):4489-99. PubMed ID: 23315869
[TBL] [Abstract][Full Text] [Related]
38. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.
Stumptner P; Benaroch P
EMBO J; 1997 Oct; 16(19):5807-18. PubMed ID: 9312039
[TBL] [Abstract][Full Text] [Related]
39. The intracellular localization and oligomerization of chicken invariant chain with major histocompatibility complex class II subunits.
Ye H; Xu FZ; Yu WY
Poult Sci; 2009 Aug; 88(8):1594-600. PubMed ID: 19590073
[TBL] [Abstract][Full Text] [Related]
40. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]